Skip to content

The role of glucagon secreton for glycemic control in patients with type 1 diabetes or pancreatic diabetes

The role of glucagon secreton for glycemic control in patients with type 1 diabetes or pancreatic diabetes - Glucagon secreton in patients with type 1 diabetes or pancreatic diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020156
Enrollment
100
Registered
2015-12-10
Start date
2015-12-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes, Pancreatic diabetes

Interventions

None listed

Sponsors

Nagasaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Type 1 diabetes Pancreatic diabetes

Exclusion criteria

Exclusion criteria: Pregnant women Women who lactates

Design outcomes

Primary

MeasureTime frame
The relationship of glucagon secretion and fluctuation of glucose revels.

Countries

Japan

Contacts

Public ContactIchiro Horie

Nagasaki University Hospital Endocrinology and Metabolism

holy197741@me.com0958197262

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026